Clinical Benefit for Patients with Non-Small Cell Lung Cancer Enrolled in Phase I Trials

Publisher： Karger

E-ISSN： 2296-5262|36|6|357-362

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.36, Iss.6, 2013-05, pp. : 357-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials

By  

Oncology, Vol. 91, Iss. 4, 2016-07 ,pp. : 185-193

Karger

Access to resources Recommend Favorite

Clinical Characteristics of 274 Non-Small Cell Lung Cancer Patients in China

By  

Oncology Research and Treatment, Vol. 36, Iss. 5, 2013-04 ,pp. : 248-254

Karger

Access to resources Recommend Favorite

Vinorelbine-Based Regimens as Salvage Treatment in Patients with Advanced Non-Small Cell Lung Cancer: Two Parallel Multicenter Phase II Trials

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 235-241

Karger

Access to resources Recommend Favorite

Erlotinib versus Pemetrexed for Pretreated Non-Squamous Non-Small Cell Lung Cancer Patients in Clinical Practice

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 255-264

Karger

Access to resources Recommend Favorite

Clinical Phase II Trial of Treosulfan in Patients with Non-Resectable Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 316-319

Karger

Access to resources Recommend Favorite